EASYER (EpiAccess SYstem Registry) A Post Market Observational Registry

NCT02481102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2021-02-10

No results posted yet for this study

Summary

The objective of the Registry is to provide post market clinical outcome and potential health economics data and confirm the continued safety of the EpiAccess system.

Conditions

  • Arrhythmias, Cardiac

Sponsors & Collaborators

  • EpiEP, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrea Natale, MD · Texas Cardiac Arrhythmia Research Foundation

  • Vivek Reddy, MD · Icahn School of Medicine, Mount Sinai Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2021-02-09
Completion
2021-02-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02481102 on ClinicalTrials.gov